摘要
自2019年12月武汉爆发新型冠状病毒肺炎疫情以来,全国上下紧急动员应对疫情,医药界迅速启动对新型冠状病毒的研究以及相关诊断治疗药物的研发。本文基于以往关于SARS-CoV和MERS-CoV的文献信息以及最近公开的2019-nCoV研究结果,跟踪相关研究的最新进展,对冠状病毒治疗性抗体的专利现状和发展趋势进行了分析。
Since the outbreak of the COVID-19 in Wuhan in December 2019,emergency mobilization has been mobilized throughout the country to carry out epidemic prevention and control work.The medical community has quickly started research on the 2019-nCoV and the development of related diagnostic and therapeutic drugs.Based on the previous literature information on SARS-CoV and MERS-CoV and the recently published 2019-nCoV research results,this article tracks the latest developments in related research,and analyzes the status and development trends of patents for therapeutic antibodies against coronavirus.
作者
杨振宇
张临政
刘俊香
YANG Zhenyu;ZHANG Linzheng;LIU Junxiang(Pharmaceutical and Biological Invention Examination Department of the Patent Office,CNIPA,Beijing 100088)
出处
《中国发明与专利》
2020年第3期23-29,共7页
China Invention & Patent